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Abstract
Background: Methicillin-resistant Staphylococcus aureus (MRSA) is a global epidemic threat. The aim of this study
was to determine which globally known MRSA lineages are currently present at our tertiary care hospital in
Switzerland, a hospital with low MRSA prevalence. In light of the increasing prevalence of multi drug resistance
including vancomycin resistance we also assessed antibiotic susceptibilities.
Methods: The 146 MRSA strains collected over two years (March 2012 until February 2014) at the University
Hospital Zurich, Switzerland, were analyzed by PFGE analysis of SmaI digests in combination with spa-typing. In
addition, representative isolates were analyzed by multi locus sequence typing (MLST). Susceptibilities to eight
antibiotics were assessed using the Kirby-Bauer disc diffusion method.
Results: Isolates showed resistance to erythromycin (48%), ciprofloxacin (43%), clindamycin (31%), tetracycline
(22%), and gentamicin (16%). All isolates were susceptible to vancomycin, 95% were susceptible to
sulfamethoxazole/trimethoprim and rifampicin, respectively. PFGE analysis revealed 22 different patterns, with four
major patterns that accounted for 53.4% of all MRSA isolates, and seven sporadic patterns. Spa typing revealed 50
different spa types with the predominant types being t008 (14%), t002 (10%), and t127 (9%). 82% of the MRSA
isolates could be assigned to six clonal complexes (CCs) namely CC1 (10%), CC5 (23%), CC8 (18%), CC22 (17%),
CC30 (11%), and CC45 (3%) based on spa-types, PFGE patterns, and MLST. Two isolates could not be typed by
either PFGE analysis or spa-typing and three isolates had spa-types that have not yet been described.
Conclusions: The combination of the two typing methods was more discriminatory as compared to the use of a
single method. Several of the lineages that are predominant in Europe are present in our hospital. Resistances to
antibiotics have decreased in comparison to a study conducted between 2004 and 2006.
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Background
Methicillin-resistant Staphylococcus aureus (MRSA) is
one of the major causes of healthcare-associated infec-
tions worldwide [1]. In addition, the increasing preva-
lence of multi drug resistance including vancomycin
resistance emphasizes the importance of infection con-
trol measures such as MRSA typing. There are consider-
able variations in the prevalence of MRSA according to
geographic area and rates reach over 50% in some re-
gions of the world (Reviewed by Stefani et al. 2012 [2]).
Most MRSA strains belong to a few distinct pandemic
lineages. The current terminology to describe S. aureus
lineages is based on the clonal complexes (CCs) identi-
fied by multilocus sequence typing (MLST). MLST in-
volves the sequencing of seven housekeeping genes and
each unique allelic profile is assigned a sequence type
(ST) [3]. Clonal complexes are defined as groups of STs
in which every ST shares at least five of seven identical
alleles with at least one other ST in the group [4]. Even
though numerous studies have used whole genome se-
quencing to explore the local and global dissemination
of distinct lineages recently (for example [5]), MLST is
still considered the “gold standard” of typing. But since
for MLST seven house-keeping genes have to be se-
quenced it is expensive and time-consuming. Therefore,
many epidemiological studies have used spa-typing,
which includes the sequencing of the polymorphic re-
peat region of protein A [6]. In the meantime, most CCs
can be predicted from spa-types using previous publica-
tions (for example [7]) or the ridom spa-server (http://
spa.ridom.de/spatypes.shtml [8]). Other methods cur-
rently used to type MRSA include SCCmec typing, or
multilocus variable-number tandem repeats analysis
(MLVA), and were recently reviewed [2]. SCCmec typing
uses a defined nomenclature, but there are several typing
and subtyping schemes that are not harmonized, and the
discriminatory power of this method is limited. Even
though MLVA is rapid, high-throughput and has high
discriminatory power, no standard methodology or no-
menclature has been defined, which makes this method
less suitable for assessing long-term and global epidemi-
ology [9].
Especially before the introduction of sequence-based
approaches pulsed field gel electrophoresis (PFGE) used
to be the “gold standard” of MRSA typing [10]. PFGE
analysis is very convenient and has high discriminatory
power. PFGE is still widely used for short-term, local
epidemiology, and to identify outbreaks. However, it is
less suited for studying long-term and global epidemi-
ology since it does not permit to compare between cen-
ters. This is reflected by the fact that PFGE patterns (e.g.
numbers) used at our hospital are only valid for strains
typed at our hospital. In addition, it is challenging to
compare PFGE data over long time periods, since several
variables (i.e. devices and personnel) might change over
time and since PFGE analysis is, at least to a certain
degree, a matter of subjective interpretation, i.e. whether a
weak band is assessed or not.
All MRSA isolates collected at our hospital, a tertiary
care hospital in Switzerland with low MRSA prevalence
(3-6%, [11]), have been analyzed by PFGE since 1992
within the scope of our local isolation management. The
objectives of the current study were to combine the PFGE
data with an additional typing method (spa-typing), and to
determine which of the globally known clones were found
at our hospital during a two-year study period. MLST
served as reference. In addition, antibiotic susceptibilities
of the MRSA strains were assessed.
Methods
Bacterial strains
All consecutive, non-duplicate MRSA strains collected
at the University Hospital Zurich, Switzerland between
March 2012 and February 2014 were included in the
study. Isolates included MRSA from patients with infec-
tions (including three bacteremias) as well as from colo-
nized individuals. Several reference strains were obtained
from the Network on Antimicrobial Resistance in Sta-
phylococcus aureus (NARSA) and included USA300-114
(ST8), USA100 (ST5), USA1100 (ST30), USA400 (ST1),
USA700 (ST72), and USA500 (ST8). EMRSA-15 (ST22)
was a kind gift of Dr. Patrice François (Geneva, Switzerland).
Strain CHE482 (ST45) has been previously described [12].
Methicillin resistance detection
Isolates were identified as S. aureus by StaphAureux tests
(Remel, Kent, UK). Methicillin resistance was detected by
testing cefoxitin resistance using the Kirby-Bauer disc dif-
fusion method [13] and/or by detection of the penicillin
binding protein 2a (PBP2a) using the MRSA Screen kit
(Denka Seiken Co., Ltd., Tokyo, Japan).
Susceptibility testing
Resistance levels for ciprofloxacin, clindamycin, erythro-
mycin, rifampicin, tetracycline, gentamicin, sulfameth-
oxazole/trimethoprim, and vancomycin were determined
by disk diffusion according to EUCAST guidelines [13].
To compare susceptibility patterns of the current strain
collection with a collection from a previous study that
has been conducted in 2007 [11], susceptibilities were
also interpreted using CLSI guidelines [14]. Intermediate
resistance and inducible resistance were assumed to be
resistant.
Molecular typing
PFGE typing was done with SmaI digests according to
standard protocols and analyzed using the BioNumerics
software package (Applied Maths, Belgium). The dice
Seidl et al. Annals of Clinical Microbiology and Antimicrobials  (2015) 14:14 Page 2 of 7
coefficient was used with 1.25% optimization and 1% tol-
erance to calculate similarities between PFGE patterns.
Isolates with >80% identity were considered identical.
Isolates with similar PFGE patterns (70% identity) were
assigned with letters (e.g. 21a). Numbers were assigned
to isolates that occurred at least three times in our
laboratory including isolates from other hospitals and
isolates that were collected before 2012. Therefore, some
of the PFGE patterns only occurred once in this study
but have a number. Spa sequence typing of the poly-
morphic repeat regions of protein A [6] was performed
using the Ridom StaphType spa-sequencing protocol and
the spaTyper (http://spatyper.fortinbras.us/). Multi-locus
sequence typing (MLST) of representative isolates was
performed as described [3] and sequence types (STs) were
derived using the MLST database (http://www.mlst.net).
Results and discussion
Resistance patterns
Of the 146 isolates 48% showed resistance (or intermedi-
ate resistance) to erythromycin, 43% to ciprofloxacin,
31% to clindamycin (of which 14% were inducible), 22%
to tetracycline, and 16% to gentamicin (Table 1). All of
the 146 isolates were susceptible to vancomycin, and
95% of isolates were susceptible to sulfamethoxazole/tri-
methoprim and rifampicin, respectively (Table 1). Thirty
seven isolates (25%) were susceptible to all antibiotics
other than oxacillin. There was a decrease in resistances
to ciprofloxacin, erythromycin, gentamicin, rifampicin,
and tetracycline as compared to MRSA strains collected
between 2004 and 2006 at our hospital [11]. In this previous
study, 67% of isolates were resistant to ciprofloxacin (25%
more than in the current study), 57% to erythromycin (9%
more), 34% to tetracycline (12% more), 22% to gentamicin
(7% more), and 11% to rifampicin (6% more). No informa-
tion was available about the resistance towards sulfameth-
oxazole/trimethoprim or whether the clindamycin-resistant
strains exhibited inducible resistance. Because some of the
changes in resistances might be attributable to the change
in guidelines from CLSI to EUCAST we also analyzed
antibiotic susceptibilities of the current collection using
the CLSI guidelines which had been used in the previous
study [14]. Decreases were identical for ciprofloxacin,
erythromycin, and tetracycline when applying CLSI guide-
lines. Decreases in resistance to gentamicin and rifampicin
were slightly higher (9% and 7% less resistant strains in
the current vs. the previous study, respectively).
Multiresistance to one, two, three, four, five, and six
antibiotics in addition to oxacillin was observed for 29%,
15%, 20%, 8%, 1%, and 3%, of the isolates, respectively
(Table 1). The most prominent combinations of resistan-
ces are shown in Table 1. Together, ~30% of the MRSA
strains isolated were resistant to at least four antimicrobial
agents (including oxacillin), emphasizing that antibiotic
resistance remains a problem. These findings underline
the importance of infection control measures.
PFGE analyses
Of the 146 isolates 136 isolates were grouped into 22
PFGE patterns. The four most frequent PFGE patterns
were PFGE-21 (n = 27, 19%), PFGE-20 (n = 20, 14%),
PFGE-08 (n = 16, 11%) and PFGE-41 (n = 15, 10%), and
together made up more than 50% of all isolates (Figure 1a).
Nine isolates had a pattern that had never occurred in our
Table 1 Resistance phenotypes of MRSA
Resistance profile No. (%) of isolates
Individual antibiotics
Erythromycin 70 (47.9)
Ciprofloxacin 62 (42.5)
Clindamycin (including inducible resistance) 45 (30.8)
(Inducible Clindamycin resistance) 20 (13.7))
Tetracycline 32 (21.9)
Gentamicin 23 (15.6)
Sulfamethoxazole/trimethoprim 8 (5.4)
Rifampicin 7 (4.8)
Vancomycin 0 (0)
Multiresistance
Oxacillin + 1 antibiotic 42 (28.8)
Ciprofloxacin 16 (11.0)
Erythromycin 10 (6.8)
Tetracycline 9 (6.1)
Gentamycin 6 (4.1)
Sulfamethoxazole/trimethoprim 1 (0.7)
Oxacillin + 2 antibiotics 22 (15.1)
Ciprofloxacin + erythromycin 7 (4.8)
Clindamycin + erythromycin 6 (4.1)
Erythromycin + tetracycline 3 (2.1)
Other combinations* 6 (4.1)
Oxacillin + 3 antibiotics 29 (19.7)
Ciprofloxacin + clindamycin + erythromycin 16 (11.0)
Ciprofloxacin + erythromycin + tetracyclin 7 (4.8)
Other combinations* 6 (4.1)
Oxacillin + 4 antibiotics 11 (7.5)
Ciprofloxacin + clindamycin +
erythromycin + gentamicin
6 (4.1)
Other combinations* 5 (3.5)
Oxacillin + 5 antibiotics* 1 (0.7)
Oxacillin + 6 antibiotics* 4 (2.7)
Ciprofloxacin + clindamycin + erythromycin +
tetracyclin + rifampicin + gentamicin
3 (2.1)
*Combinations that occurred less than three times are not specified. Bold
numbers indicate the total number of each subgroup.
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laboratory and were therefore not assigned a number.
One isolate (MRSA3687) could not be typed by PFGE
analysis (Additional file 1: Table S1).
Spa-types
The 146 isolates had 50 distinct spa-types. The three
most common spa-types were t008 (n = 21, 14%), t002
(n = 14, 10%), and t127 (n = 13, 9%) and accounted for
33% of all isolates (Figure 1b). All other spa-types oc-
curred less than ten times and 47% of all isolates had a
spa-type that occurred less than three times (Figure 1b).
One of the 146 isolates (MRSA3984) was not spa-typ-
able (no PCR product for spa). Three isolates had
spa-types not described so far: MRSA3903 (T1-J1-J1-
*-J1-N1-F2-M1-N1-F2-M1-O1-O1-K1-R1) had a repeat
that differed in one nucleotide from repeat r13 (E1).
MRSA 3771 had a new combination of spa-repeats
(T1-N1-F2-M1-O1-M1-O1-O1-R1) as well as MRSA3670
(U1-J2-G1-M1-K1-M1-K1-K1-P1-N1-S1-G1, Additional
file 1: Table S1).
The two most common spa-types found in this study
(t008 and t002) were among the most frequent spa-types
in MRSA blood stream isolates collected all over Europe
from 2006 to 2007 [15]. In contrast to this previous
study, our MRSA strains were derived from various in-
fections including three blood stream isolates (one of
which was of t008) as well as from colonized patients.
We thus provide information on both invasive and col-
onizing MRSA strains. In contrast, we have no infor-
mation whether the European blood stream isolates
represent the MRSA circulating in the population. Spa-
type t127, our third most common spa-type, was only
sporadically identified in the European blood stream iso-
lates [15]. However, this spa-type has been identified as
a common MRSA lineage in pigs in Europe, mainly in
Italy [16]. Several common spa-types found in European
blood stream isolates e.g. t032 (14.5%) or t041 (7.4%)
only occurred sporadically in our hospital (t032 (5%)) or
were absent (t041). In contrast, t041 was the local epi-
demic spa-type of MRSA isolates (including invasive and
colonizing isolates) at the University Hospital Basel,
Switzerland between 2000 and 2005 [17], another low-
prevalence hospital less than 100 kilometers away from
our hospital.
Correlation between PFGE analyses and spa-typing
Results of PFGE analyses and spa-typing are shown in
Figure 2. All isolates were typable by at least one of the
two methods. Two isolates could not be typed by either
PFGE analysis or spa-typing. Both phenomena have been
previously described and were reported to be due to
methylation of the SmaI restriction site as well as due to
mutations of the protein A gene spa, respectively [18,19].
In most of the cases, isolates with identical PFGE pat-
terns had identical or related spa-types. Only two isolates
(MRSA3548 and MRSA3619) which were both of spa-
type t127 were both singletons with low similarity (~50%)
to the other t127 isolates (Figure 2).
Different PFGE patterns shared common spa-types (e.g.
PFGE-41 and 49 both included spa-type t008). Vice versa,
several strains with different spa-types shared the same
PFGE patterns (e.g. PFGE-21 included seven different
spa-types, Figure 2). These findings emphasize that the
combination of both methods is more discriminatory as
compared to using one method only as has been described
previously [20].
Clonal complex 5
Thirty-four isolates were of spa-types t002, t003, t010,
t067, t179 or t688 that corresponded to CC5 [7,8,21,22].
These 34 isolates were grouped into three related PFGE-
patterns (PFGE-21, 48, and 87 (Figure 2)), one of which
(PFGE-21) was identical to USA100 (ST5, CC5). MLST
of representative PFGE-21/t002 and PFGE-48/t688
isolates confirmed that both were of ST5, CC5. ST5
was one of the predominant MRSA clones among blood
culture isolates in Europe [15].
Clonal complex 8 and related lineages
Twenty-eight isolates were grouped into CC8 based on
their spa-types, which were t008, t064, t304, t451, t967
[22,23]. These isolates displayed the PFGE patterns 41,
49, and 26 (Figure 2). PFGE-41 had previously been iden-
tified as USA300 (ST8, CC8) [24]. This lineage is the most
Figure 1 Genetic background of MRSA. Frequencies of PFGE types (a), spa-types (b), and predicted clonal complexes (c). CC, clonal complex.
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prevalent MRSA in the United States of America (USA)
and a global epidemic threat (Reviewed by Nimmo 2012
[25]). Special care must be taken to avoid the spread of
this particular clone. The PFGE-49 pattern has been previ-
ously shown to be ST8 [24]. PFGE-26 was identical to
USA500 (ST8, CC8), and we confirmed ST8 by MLST.
Isolates that were related to CC8, but were grouped
separately as previously suggested [26], included four
isolates that were assigned to ST239 (CC8/239) based
on their spa-types t030, t037 and t969 [26]. MLST of
one of these isolates confirmed that they were of ST239.
Seven isolates were of spa-types t148, t324 and t791,
t3169, which are predictive of ST72 and also related to
CC8 [26]. These isolates belonged to PFGE-51 (n = 4) or
PFGE-55 (n = 3). PFGE-51 exhibited >70% identity with
USA700 (ST72) and MLST confirmed that PFGE-51 was
ST72.
Clonal complex 22
Twenty-four isolates were of spa-types t005, t032, t492,
t515, t852, t1771, t4325, t4559 (Table 1), which was
predictive of CC22 [8,27]. Twenty of these isolates
(PFGE-20) were identical to EMRSA-15 (ST-22, CC22) in
terms of PFGE-restriction patterns. MLST of a representa-
tive isolate confirmed that these isolates were of ST22.
EMRSA-15 (ST22) was also widely distributed among
Figure 2 Correlation between PFGE analyses and spa-typing. Genetic relationships between the 146 MRSA isolates, correlations between
PFGE typing and spa-typing (spa). Strains presented were sorted according to PFGE patterns and similarities of spa-types. Shown are strains of
clonal complexes (CC) that occurred at least four times. Reference strains are marked with grey boxes. ST, Sequence type.
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MRSA blood stream isolates in Europe [15]. The other
four isolates were of PFGE-82, which was also of ST22
and PFGE-63, which was of ST1327, a sequence type that
differs in one allele (pta) from ST22 (Figure 2).
Clonal complex 30
Sixteen isolates had spa-types t019, t318 and t685, which
are indicative of CC30 [22]. All of these isolates had the
PFGE-08 pattern, which exhibited at least 80% identity
to USA1100 (ST30, CC30). MLST of a representative
PFGE-08 isolate confirmed that it was of ST30.
Clonal complex 1
Fourteen isolates were of spa-type t127 and the related
spa-type t5100 which was assigned to CC1 [22]. These
isolates had PFGE-18 (n = 6) and PFGE-72 (n = 6) patterns
and two isolates were singletons. PFGE-72 exhibited >80%
similarity to USA400 (ST1, CC1). MLST of a PFGE-72/
t127 isolate confirmed that it was of ST1, confirming its
grouping into CC1 (Figure 2).
Clonal complex 45
Five isolates were of spa-types t004, t015 or t282, which
are predictive of CC45 [8], a lineage that is common in
Europe [2]. These isolates were of PFGE-19, which is
identical to the Swiss drug clone CHE482-ST45 [12].
MLST of a representative PFGE-19 isolate confirmed
that it was ST45. The Swiss drug clone is a community
acquired MRSA (CA-MRSA) clone, which was spread
among injection drug users, was predominant at our
hospital between 1998 and 2004 [11], and still occurs
sporadically.
Summary of clonal complexes
Four isolates were of spa-types t448, t730 and t784,
being indicative of CC88 [28]. MLST of one of these iso-
lates confirmed that it was ST88. The remaining thirteen
isolates were of diverse genetic backgrounds (Additional
file 1: Table S1). Together, 82% of the MRSA isolates
could be grouped into the six clonal complexes (CCs):
CC1 (10%), CC5 (23%), CC8 (18%), CC22 (17%), CC30
(11%), and CC45 (3%) based on their PFGE pattern,
spa types, MLST and previously published literature
(Figure 1c).
Correlation between genetic background and antibiotic
sucseptibility
Additional file 1: Table S1 shows the antibiograms of the
individual MRSA strains. While some clones, such as
PFGE-21a/t002 or PFGE-41/t008 showed high heterogen-
eity in their antibiograms, other clones had homogenous
resistance patterns. Spa/PFGE-types that shared identical
antibiograms included t003 isolates (n = 5, PFGE-21b,
CC5), t688 isolates (n = 4, PFGE-48, CC5), t685 isolates
(n = 5, PFGE-08 and PFGE-08a, CC30), t005 (n = 4,
PFGE-20 and PFGE-63, CC22), t282 isolates (n = 3,
PFGE-19, CC45), and PFGE-51 isolates (n = 4, t791 or
t324, ST72) (Additional file 1: Table S1). Interestingly,
all four ST239 isolates were resistant to six antibiotics
in addition to oxacillin, which is in accordance with pre-
vious findings, in which ST239 has been described as
multi resistant [5].
Conclusions
In summary, we have demonstrated that i) several of the
lineages that are predominant in Europe are present in
our hospital, ii) the combination of PFGE and spa-typing
is more discriminatory as compared to using a single
method only and will allow to better monitor and recog-
nize changes in MRSA epidemiology over time, iii) clonal
complex predictions based on PFGE and spa-typing could
be confirmed by MLST, and iv) there was a decrease in
resistances to ciprofloxacin, erythromycin, gentamicin, ri-
fampicin, and tetracycline as compared to MRSA strains
collected in an earlier period.
Additional file
Additional file 1: Table S1. Genetic background and antibiogramms of
all 146 MRSA isolates.
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